General cardiology: Myocarditis, pericarditis and other pericardial diseases

Heart

Volumn 84, Issue 4, 2000, Pages 449-454

  Oakley, Celia M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; COLCHICINE;

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART TAMPONADE; HUMAN; MYOCARDITIS; PERICARDIAL DISEASE; PERICARDITIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RESTRICTIVE CARDIOMYOPATHY; UNITED KINGDOM; ACUTE DISEASE; CARDIOMYOPATHY; CONSTRICTIVE PERICARDITIS; ELECTROCARDIOGRAPHY; FEMALE; MALE; MICROBIOLOGY; PERICARDIOCENTESIS; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ACUTE DISEASE; CARDIAC TAMPONADE; CARDIOMYOPATHIES; COLCHICINE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDITIS; PERICARDIOCENTESIS; PERICARDITIS; PERICARDITIS, CONSTRICTIVE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0034297085     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.4.449     Document Type: Article

References (19)

1. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death in learning from the past for the future. Circulation 1999;99:1091-100. The molecular analysis of necropsy and endomyocardial biopsy specimens has clarified the causal link between myocarditis and dilated cardiomyopathy.
2. Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis. Viral pathogenesis through replication, cytokine induction and immunopathogenicity. Adv Virus Res 1998;51:35-80.
3. Bachmaier K, Neu N, de la Masa LM, et al. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1335-9.
4. Bewles NE, Towbin JA. Molecular aspects of myocarditis. Current Opinion in Cardiology 1998;13:179-84. The pathogenesis of myocarditis remains elusive. The crucial roles of cytokine expression and of aberrant induction of apoptosis are being defined.
5. Karjalainen J, Heikkila J. Incidence of three presentations of acute myocarditis in young men in military service: a 20 year experience. Eur Heart J 1999;20:1120-5. The usual presentation mimics myocardial infarction (98 cases); only one presented with sudden death and nine as dilated cardiomyopathy of recent origin.
6. Smith SC, Ladenson JH, Mason JW, et al. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlations. Circulation 1997;95:163-8. Many patients have elevated troponin or creatine kinase MB if studied during the first week of the disease. When found in a patient with chest pain and ECG ST segment elevation on presentation, the clinical similarity with myocardial infarction caused by coronary thrombosis may be complete.
7. Aretz HT, Billingham ME, Edwards WD. Myocarditis: a histopathological definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
8. Mason JW. Myocarditis. Adv Intern Med 1999;44:293-310.
9. Brodison A, Swann JW. Myocarditis: a review. J Infection 1998;37:99-103. Means of early identification are needed to prevent progression to chronic heart failure by more satisfactory therapies.
10. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy of myocarditis. The myocarditis treatment trial investigators. N Engl J Med 1995;333:269-75.
11. Friman G, Ilback NG. Acute infection: metabolic responses, effects on performance, interaction with exercise and myocarditis. Int J Sports Med 1998;19(suppl 35):172-82.
12. Anandasabathy S, Frishman WH. Innovative drug treatments for viral and auto-immune myocarditis. J Clin Pharmacol 1998;38:295-308. Better means of distinguishing between viral and autoimmune causes are needed so that treatment can be appropriate. A useful review of treatments.
13. Lieberman EB, Hutchins GM, Herskowitz A, et al. Clinico-pathological description of myocardititis. Am J Cardiol 1991;18:1617-26.
14. McCarthy RE, Boeehmer P, Hruban RH, et al. Long term outlook of fulminant myocarditis as compared with acute (non-fulminant) myocarditis. N Engl J Med 2000;342:690-5.
15. Midei MG, De Ment SH, Feldman AM, et al. Peripartum myocarditis and cardiomyopathy. Circulation 1990;81: 922-8. Changes of acute myocarditis are found in a high proportion of cases if biopsies are obtained within a month of onset.
16. Karjalainen J, Heikkila J. "Acute pericarditis" myocardial enzyme release as evidence for myocarditis. Am Heart J 1986;111:546-52. Myocardial enzyme release is uncommon without simultaneous ST-segment elevation in suspected acute myocarditis.
17. Adler Y, Finkelstein Y, Guindo J, et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation 1998;97:2183-5. Colchicine is probably the treatment of first choice for recurrent pericarditis, especially when the origin is idiopathic.
18. Arsura EL, Kilgore WB, Strategos E. Purulent pericarditis misdiagnosed as septic shock. Southern Med J 1992;92:285-8. Failure to recognise purulent pericarditis and tamponade may be fatal in bacteraemic patients. In contrast to patients with septic shock, patients with tamponade have high systemic vascular resistance and low cardiac output.
19. Maisch B, Pankuneit S, Brilla C, et al. Intrapericardial treatment of inflammatory and neoplastic pericarditis guided bv pericardioscopy and epicardial biopsy results from a pilot study. Clin Cardiol 1999;22(supp 1):117-22.